View in EDS HTML Full Text PDF Full Text

Immunogenicity and safety of anti‐SARS‐CoV‐2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs.

Saved in:
Bibliographic Details
Title: Immunogenicity and safety of anti‐SARS‐CoV‐2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs.
Authors: Cristaudo, A.1 (AUTHOR), Graceffa, D.1 (AUTHOR) dario.graceffa@ifo.gov.it, Pimpinelli, F.2 (AUTHOR), Sperati, F.3 (AUTHOR), Spoletini, G.4 (AUTHOR), Bonifati, C.1 (AUTHOR), Pellini, R.5 (AUTHOR), Lora, V.1 (AUTHOR), Pontone, M.2 (AUTHOR), Di Bella, O.6 (AUTHOR), Bracco, D.6 (AUTHOR), Morrone, A.7 (AUTHOR)
Source: Journal of the European Academy of Dermatology & Venereology. Apr2022, Vol. 36 Issue 4, pe266-e268. 3p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09269959
DOI:10.1111/jdv.17861